Tag: biosimilars vs generics
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Computer Vision Syndrome: Simple Ways to Prevent Digital Eye Strain
Mar, 11 2026
A Deep Dive Into ozmedsonline.com: How Online Pharmacies Are Changing Aussie Healthcare
Jul, 10 2025
How Pharmacists Are Leading the Charge in Immunizations and Generic Prescriptions
Dec, 1 2025
Closed-Loop Systems: Automated Insulin Delivery and Real-World Results
May, 7 2026
The Importance of Regular Hearing Tests for Early Detection of Hearing Difficulty
Sep, 4 2023